Drug Product Movers & Shakers Advertising in Professional Health Journals through April 2013

by Client Services

Among the top 25 drugs advertising in professional health journals from the beginning of 2013 until the end of April, there have been several large increases in dollars spent when compared to the same time period of 2012.

Print Ad Drug Products with Large Increases (Dollars): Jan. – April 2013

#1 Zytiga – $3 MM (+246%)

#2 Lyrica Capsules – $2 MM (+65%)

#3 Eliquis Tablets – $1 MM (+22,989%)

#4 Jentadueto - $775,000 (+48%)

#5 Humalog KwikPen – $766,000 (+114%)

Jentadueto is used to treat type 2 diabetes, while the Humalog KwikPen is used to treat type 1 diabetes in adults. The latter is also used in conjunction with oral medications to treat type 2 diabetes in adults.

Note that this does not include products that have launched since April 2012.

The percentage changes compare January – April 2013 to that same time period in 2012.  For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.